etomoxir has been researched along with 2-keto-4-methylvalerate in 2 studies
| Studies (etomoxir) | Trials (etomoxir) | Recent Studies (post-2010) (etomoxir) | Studies (2-keto-4-methylvalerate) | Trials (2-keto-4-methylvalerate) | Recent Studies (post-2010) (2-keto-4-methylvalerate) |
|---|---|---|---|---|---|
| 260 | 8 | 93 | 738 | 52 | 73 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Grill, VE; Zhou, YP | 1 |
| Berggren, PO; Grill, V; Zhou, YP | 1 |
2 other study(ies) available for etomoxir and 2-keto-4-methylvalerate
| Article | Year |
|---|---|
Long-term exposure of rat pancreatic islets to fatty acids inhibits glucose-induced insulin secretion and biosynthesis through a glucose fatty acid cycle.
Topics: Animals; Caprylates; Carnitine O-Palmitoyltransferase; Cells, Cultured; Epoxy Compounds; Ethanol; Fatty Acids, Nonesterified; Glucose; Hypoglycemic Agents; Insulin; Insulin Secretion; Islets of Langerhans; Keto Acids; Kinetics; Male; Oleic Acid; Oleic Acids; Palmitic Acid; Palmitic Acids; Proinsulin; Protein Biosynthesis; Proteins; Rats; Rats, Sprague-Dawley; Time Factors | 1994 |
A fatty acid-induced decrease in pyruvate dehydrogenase activity is an important determinant of beta-cell dysfunction in the obese diabetic db/db mouse.
Topics: Aging; Animals; Carnitine O-Palmitoyltransferase; Cells, Cultured; Crosses, Genetic; Diabetes Mellitus; DNA; Enzyme Inhibitors; Epoxy Compounds; Fatty Acids, Nonesterified; Female; Glucose; Hyperglycemia; Hyperinsulinism; Insulin; Insulin Secretion; Islets of Langerhans; Keto Acids; Kinetics; Male; Mice; Mice, Inbred C57BL; Mice, Obese; Mitochondria; Obesity; Pyruvate Dehydrogenase Complex | 1996 |